18 research outputs found
Edge Computing For Smart Health: Context-aware Approaches, Opportunities, and Challenges
Improving the efficiency of healthcare systems is a top national interest worldwide. However, the need to deliver scalable healthcare services to patients while reducing costs is a challenging issue. Among the most promising approaches for enabling smart healthcare (s-health) are edge-computing capabilities and next-generation wireless networking technologies that can provide real-time and cost-effective patient remote monitoring. In this article, we present our vision of exploiting MEC for s-health applications. We envision a MEC-based architecture and discuss the benefits that it can bring to realize in-network and context-aware processing so that the s-health requirements are met. We then present two main functionalities that can be implemented leveraging such an architecture to provide efficient data delivery, namely, multimodal data compression and edge-based feature extraction for event detection. The former allows efficient and low distortion compression, while the latter ensures high-reliability and fast response in case of emergency applications. Finally, we discuss the main challenges and opportunities that edge computing could provide and possible directions for future research
A Deep Learning Approach for Vital Signs Compression and Energy Efficient Delivery in mhealth Systems
© 2013 IEEE. Due to the increasing number of chronic disease patients, continuous health monitoring has become the top priority for health-care providers and has posed a major stimulus for the development of scalable and energy efficient mobile health systems. Collected data in such systems are highly critical and can be affected by wireless network conditions, which in return, motivates the need for a preprocessing stage that optimizes data delivery in an adaptive manner with respect to network dynamics. We present in this paper adaptive single and multiple modality data compression schemes based on deep learning approach, which consider acquired data characteristics and network dynamics for providing energy efficient data delivery. Results indicate that: 1) the proposed adaptive single modality compression scheme outperforms conventional compression methods by 13.24% and 43.75% reductions in distortion and processing time, respectively; 2) the proposed adaptive multiple modality compression further decreases the distortion by 3.71% and 72.37% when compared with the proposed single modality scheme and conventional methods through leveraging inter-modality correlations; and 3) adaptive multiple modality compression demonstrates its efficiency in terms of energy consumption, computational complexity, and responding to different network states. Hence, our approach is suitable for mobile health applications (mHealth), where the smart preprocessing of vital signs can enhance energy consumption, reduce storage, and cut down transmission delays to the mHealth cloud.This work was supported by NPRP through the Qatar National Research Fund (a member of the Qatar Foundation) under Grant 7-684-1-127
Variability of antioxidant and biological activities of Rhus tripartitum related to phenolic compounds
Rhus species are known in traditional medicine for their therapeutic virtue and their extracts
showed numerous important properties including antimalarial, antimicrobial, antiviral, and
hypoglycemic and anticonvulsant activi- ties. Rhus tripartitum (Ucria) is a medicinal plant widely
used in Tunisia folk medicine against chronic diarrhea and gastric ulcer. This study was designed
to examine in vitro and ex vivo antioxidant, anti-inflammatory and anticancer activities of four
extracts of Rhus tripartitum root cortex with increasing solvent polarity (hexane, di-chloromethane, methanol and water). HPLC was used to identify and quantify phenolic compounds in Rhus ex- tract. Water extract showed the highest antioxidant activity using oxygen radical absorbance capacity (ORAC method) with 8.95 ± 0.47 ”mol Trolox/mg and a cell based-assay with 0.28 ± 0.12 ”mol Trolox/mg as compared to the other fractions. Moreover, methanol extract displayed the strongest anti-cancer activity against human lung carcinoma (A-549) and colon adenocarcinoma cell lines (DLD-1) with an IC50 value of 60.69 ± 2.58 and 39.83 ± 4.56 ”g/ml (resazurin test) and 44.52 ± 5.96 and 55.65 ± 6.00 ”g/ml (hoechst test), respectively.
Besides, the highest anti-inflammatory activity, inhibiting nitric oxide (NO) release, was exhibited by dichloromethane extract with 31.5 % at 160 ”g/ml in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. The HPLC analysis showed that catechol and kaempferol were the major phenolics. These data suggest the richness of all fractions of les with different polarity and confirm the known traditional therapeutics virtues of this species for the treatment of dysentery, diarrhea and gastric ulcer
Pituitary Adenylate Cyclase Activating Peptide (1-38) and its analog (Acetyl-[Ala15, Ala20] PACAP 38-polyamide) reverse methacholine airway hyperresponsiveness in rats
O objetivo deste estudo foi investigar funcionalmente e estruturalmente efeito broncodilatador do peptĂdeo ativador da adenilato ciclase pituitĂĄria (PACAP1-38) e da acetil-[Ala15, Ala20]PACAP 38-poliamida, potente anĂĄlogo do PACAP-38, nos ratos desafiados pelo metacolina (MeCh). Ratos Wistar machos foram aleatoriamente divididos em cinco grupos. Grupos 1 e 2, inalando aerossĂłis de solução salina ou doses crescentes de MeCh (0,5, 1, 2,12, 4,25, 8,5, 17, 34 e 68 mg/L). Os outros grupos recebendo terbutalina (Terb) (250 ”g/rato) (10-6M), PACAP-38 (50 ”g/rato) (0.1 mM) ou anĂĄlogo do PACAP-38 (50 ”g/rato) associados a MeCh na dose de 4,25 mg/L. A resistĂȘncia pulmonar total (RL) foi registrada antes e 2 min apĂłs a administração de Mech pelo equipamento pneumomultiteste. A administração MeCh induziu aumento significativo e dose dependente (pThe aim of this study was to investigate both functionally and structurally bronchodilator effects of Pituitary adenylate cyclase activating peptide (PACAP38) and acetyl-[Ala15, Ala20] PACAP38-polyamide, a potent PACAP38 analog, in rats challenged by methacholine (MeCh). Male Wistar rats were divided randomly into five groups. Groups 1 and 2 inhaled respectively aerosols of saline or increasing doses of MeCh (0.5, 1, 2.12, 4.25, 8.5, 17, 34 and 68mg/L). The other groups received terbutaline (Terb) (250 ”g/rat) (10-6 M), PACAP38 (50 ”g/rat) (0.1 mM) or PACAP38 analog (50 ”g/rat) associated to MeCh from the dose of 4.25 mg/L. Total lung resistances (RL) were recorded before and 2 min after MeCh administration by pneumomultitest equipment. MeCh administration induced a significant and a dose-dependent increase (
The trans-shipment problem in a two-echelon, multi-location inventory system with lost sales
International audienceAbstract
The transshipment problem in a multi-echelon inventory system with lost sales
International audienc
Gestion de stocks avec transshipment dans un réseau de distribution multi sites et multi échelons
International audienc
Effects of Lupinus luteus on hepatic and renal extracellular compounds turnover under diabetes in rat
Abstract Hepatic and renal extracellular matrix (ECM) turnover associated with diabetes and potential beneficial effects of yellow lupin extract (YLE) need further investigations. The aim of this study was to explore the effect of yellow Lupinus luteus extract (YLE) on renal and hepatic ECM under diabetes. Composition of YLE performed by LCâESIâMS. Diabetes (DM) was induced in rats by alloxan (250âmg/kg, ip). Normal and diabetic rats received 100âmg/kg of YLE for 1 month. ECM was assessed by ELISA. Gelatinases and collagenases were analyzed by a colorimetric assay. Histology was performed on sections of liver and kidney. In the liver, diabetes increases collagen, laminin, and fibronectin contents, respectively, by 49% (p <â.01), 56% (p <â.01), and 67% (p <â.05) compared to control rats. In the kidney, total collagen and laminin contents were increased by 91% (p <â.01) and 35% (p <â.01) in the DM group, while fibronectin content in diabetic animals and those treated with YLE remains similar to the control group. Collagenases and gelatinases activities were significantly increased by diabetes in liver and kidney. While YLE treatment abrogates diabetesâenhanced MMPs activities in liver. In diabetic rats, the liver shows signs of diffuse dilatation of the sinusoid veins and steatosis. However, the liver of diabetic rats treated with yellow lupine extract showed a normal histological aspect similar to controls. Diabetes causes hepatic and renal ECM turnover. YLE can be useful to partially improve tissue disorders induced by diabetes